Predictive accuracy of the Snakebite Severity Score for envenomation patients in the ED
Official title: A Prospective Study to Determine the Predictive Accuracy of Snakebite Severity Score (SSS) in Identifying Syndrome-Specific Core Outcome Parameters Amongst Envenomated Patients Presenting to the Emergency Department.
Run by Jubilee Mission Medical College and Research Institute · NCT07079137 · Data updated 2026-11-12
This study tests whether the Snakebite Severity Score given at arrival can predict key outcomes in adults with suspected snakebites in India.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 220 (estimated) |
| Sponsor | Jubilee Mission Medical College and Research Institute Academic / other |
| Locations | 1 site (Thrissur, Kerala) |
| Status | Recruiting |
| Started | June 14, 2025 |
| Main results expected | July 30, 2027 |
| Study ends | July 30, 2027 |
| Registry record updated | August 18, 2026 |
| Trial ID | NCT07079137 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) presenting within 24 hours of a clinically suspected snakebite at Jubilee Mission Medical College and Research Institute.
✕Probably not a fit
Patients with non-snake bites, prior antivenom exposure at another institution, or with certain preexisting conditions may not benefit from the SSS approach studied.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study in Thrissur, Kerala, investigates how well the Snakebite Severity Score (SSS) at presentation predicts syndrome-specific outcomes in patients with suspected snakebites. It analyzes how regional venom differences and care delays affect outcomes and whether SSS can guide antivenom use. Participants are adults presenting within 24 hours of a suspected bite, with data collected from history, exam, bite documentation, SSS scoring, and baseline labs per institutional protocol. The aim is to improve risk stratification and support rural healthcare infrastructure by informing treatment decisions and resource use.
Why it matters
Potential benefit: If successful, the study could improve risk stratification and help guide antivenom use to reduce complications and mortality.
How similar studies have gone: Existing snakebite scoring tools have shown promise in various settings, but local validation in Indian envenomation patterns remains limited and needed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients 'clinically suspected snakebite' * Presenting within 24 hours of the event * Age ≥18 years * Providing written informed consent Exclusion Criteria: * Stings or bites other than snake * All patients who received antivenom or blood products at another institute * All patients with known hematological malignancies, coagulation disorders, chronic liver or renal failure * All patients known to be on warfarin, heparin or any newer oral or injectable anticoagulants * Individuals withdrawing a consent later on.
Where it's running
-
Jubilee Medical Mission and Research Institute
Thrissur, Kerala, India Recruiting
Study contacts
- Study coordinator: Feba Susan Kurian, MBBS
- Email: febasusankurian1999@gmail.com
- Phone: 919061984552
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing pressure pad versus pressure bandage immobilisation for snakebite first aid in healthy adults
This test will see if a pressure pad works as well as the standard pressure bandage at slowing the spread of a mock venom in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.